RNAi-mediated β-catenin Inhibition Impairs Tumor Growth in Multiple Immunocompetent CTNNB1-mutated HCC Mouse Models in Late-stage Disease Setting with Response Associated with Restored Adaptive Immune Surveillance. This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.